Sponsored Content by SartoriusReviewed by Maria OsipovaNov 7 2024
The life science group Sartorius has released its second edition of the “High-Throughput Screening (HTS) by Cytometry” handbook, tailored to support new and experienced researchers who use flow cytometry and want to learn more about HTS cytometry’s special abilities.
Those utilizing conventional systems will discover how the speed, efficiency, and ease of use provided by the iQue® HTS by Cytometry Platform can aid regular workflows. Laboratories already acquainted with the iQue® Platform may use this handbook to gain information about novel reagents, assay kits, and software releases.
This routine publication contains up-to-date Sartorius publications, allowing researchers to remain informed about the most novel use cases with HTS by cytometry in well-known and developing domains.
Research labs today face immense pressure to design more vast and complex screening approaches, often with limited samples, resources, and expertise. The use of more complex cell models, such as stem cells or patient-specific materials, adds another layer of complexity, requiring more sophisticated analysis for meaningful data, and in less time.”
Jonah Riddell, PhD, Sartorius Product Manager for iQue® Platform
“Workflows that provide these capabilities and empower scientists to make better decisions are crucial for being first-to-publish or first-to-market. As the leading experts in HTS cytometry, we created this handbook to demonstrate how this powerful technology meets the unique demands of high-throughput screening campaigns.”
Flow cytometry technology is continuously evolving to respond to the demands of laboratories engineering revolutionary medicines. The iQue® HTS Cytometry Platform was specially developed to meet this increasing need for speed and efficiency.
This publication allows readers to easily browse through topics of interest, using resources such as detailed workflow depictions, in-depth application examples, and direct links to external resources for additional learning.
Chapters underline iQue® HTS use cases in cell health, secreted proteins, cell line development, biologics discovery, immune cell models, and cell therapies, including areas on novel antibody modalities and advanced cell models, such as stem cells and organoids.
This handbook further discusses the integrated iQue Forecyt® software, which replaces the multiple data analysis packages usually necessary in other protocols. This informative publication also depicts its instantaneous data visualization, smart gating, plate-level analytics, and other sophisticated instruments.
Download From Here
Sartorius is a leading international pharmaceutical and laboratory equipment supplier. With our innovative products and services, we are helping our customers across the entire globe to implement their complex and quality-critical biomanufacturing and laboratory processes reliably and economically.
The Group companies are united under the roof of Sartorius AG, which is listed on the Frankfurt Stock Exchange and holds the majority stake in Sartorius Stedim Biotech S.A. Quoted on the Paris Stock Exchange, this subgroup is comprised mainly of the Bioprocess Solutions Division.
Innovative technologies enable medical progress
A growing number of medications are biopharmaceuticals. These are produced using living cells in complex, lengthy and expensive procedures. The Bioprocess Solutions Division provides the essential products and technologies to accomplish this.
In fact, Sartorius has been pioneering and setting the standards for single-use products that are currently used throughout all biopharmaceutical manufacturing processes.
Making lab life easier
Lab work is complex and demanding: Despite repetitive analytical routines, lab staff must perform each step in a highly concentrated and careful way for accurate results.
The Lab Products and Services Division helps lab personnel excel because its products, such as laboratory balances, pipettes and lab consumables, minimize human error, simplify workflows and reduce physical workloads
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.